The first-in-human preclinical evaluation of the new probe [123I]I-PSMA-7 for real-time intraoperative targeted biopsy and SPECT/CT imaging in prostate cancer.
Xiaohui LuanShaoxi NiuYachao LiuXiaojun ZhangXiaodan XuShuwei SunYabing SunJingfeng ZhangYuan WangZhiqiang ChenYimin ChenMengchao CuiRuimin WangXu ZhangJinming ZhangBaixuan XuPublished in: European journal of nuclear medicine and molecular imaging (2024)
Chinese Clinical trial registry ChiCTR2300069745, Registered 24 March 2023.
Keyphrases
- prostate cancer
- clinical trial
- pet ct
- endothelial cells
- high resolution
- radical prostatectomy
- computed tomography
- induced pluripotent stem cells
- image quality
- positron emission tomography
- pet imaging
- cancer therapy
- pluripotent stem cells
- ultrasound guided
- dual energy
- living cells
- contrast enhanced
- patients undergoing
- quantum dots
- cell therapy
- phase ii
- fine needle aspiration
- magnetic resonance
- drug delivery
- stem cells
- mass spectrometry
- fluorescent probe